Gryphon scientific, LLC:1143705 [18-002853]

Ended Purchase Order Awarded Last action

Contract number
HHSN261201800067P
Awardee
Awarding agency
Obligated
$13,340

Award facts

Contract value 100% obligated
$13,340.00 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
541714 Research and Development in Biotechnology (except Nanobiotechnology)
PSC
Q301 Reference Laboratory Testing
Set-aside
No set-aside
Competition
Not Competed under SAP · 1 offer Simplified Acquisition
Pricing
Fixed Price with Economic Price Adjustment
Place of performance
Bethesda, MD 20892, USA

Award details come from SAM.gov/FPDS.

About this award

The National Cancer Institute awarded a purchase order to Gryphon Scientific, LLC for $13,340.00 on December 1, 2017, with an ultimate completion date of November 30, 2018. No set-aside was used. Performance will take place in Bethesda, Maryland. The order is priced as fixed price with economic price adjustment. Specific requirements are not detailed in the source.

Quick answers

Who was awarded contract HHSN261201800067P?

HHSN261201800067P was awarded to Gryphon Scientific, LLC by National Cancer Institute (National Institutes of Health) on December 1, 2017.

How much is contract HHSN261201800067P worth?

The government has obligated $13,340 on HHSN261201800067P.

Was contract HHSN261201800067P competed?

The extent of competition for HHSN261201800067P was not competed under sap. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award